Proceeding contribution from John Bercow (Conservative) in the House of Commons on Monday, 19 May 2008. It occurred during Debate on bill and Committee of the Whole House (HC) on Human Fertilisation and Embryology Bill [Lords].
Human Fertilisation and Embryology Bill [Lords]
My hon. Friend has made it very clear that he doubts the efficacy of admixed embryo research. What is less clear is why he wants to set himself up as a monopolist, excluding lines of inquiry that others think it prudent and sensible to pursue. Why does he think that the admixed embryo—given that there will be licence conditions, and given the 14-day destruction rule—should have greater legal protection than the human embryo? So far, that point remains blindingly unclear.
Secondary information
- Type
- Proceeding contribution
- Reference
- 476 c63
- Session
- 2007-08
- Chamber / Committee
- House of Commons chamber
- Subjects
- Children Clones Animals Congenital abnormalities Fertility Licensing Human embryo experiments Diseases Donors Genetics Human Fertilisation and Embryology Authority Ethics IVF Foetal tissue Medical treatments Relatives Research Stem cells Human-animal hybrid embryos
- Legislation
- Human Fertilisation and Embryology Bill (HL) 2007-08
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 01:41:05 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474167
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474167
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474167